Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.

Chen Y, Keskin D, Sugimoto H, Kanasaki K, Phillips PE, Bizarro L, Sharpe A, LeBleu VS, Kalluri R

Open source

DOI
10.1371/journal.pbio.2005907
Published
2018 Dec
Container
PLoS biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pbio.2005907,
  title = {Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.},
  author = {Chen Y and Keskin D and Sugimoto H and Kanasaki K and Phillips PE and Bizarro L and Sharpe A and LeBleu VS and Kalluri R},
  year = {2018},
  journal = {PLoS biology},
  doi = {10.1371/journal.pbio.2005907},
  url = {https://doi.org/10.1371/journal.pbio.2005907}
}

RIS

TY  - JOUR
TI  - Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.
AU  - Chen Y
AU  - Keskin D
AU  - Sugimoto H
AU  - Kanasaki K
AU  - Phillips PE
AU  - Bizarro L
AU  - Sharpe A
AU  - LeBleu VS
AU  - Kalluri R
PY  - 2018
JO  - PLoS biology
DO  - 10.1371/journal.pbio.2005907
UR  - https://doi.org/10.1371/journal.pbio.2005907
ER  - 

APA

Y, C., D, K., H, S., K, K., PE, P., L, B., A, S., VS, L., & R, K. (2018). Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.. PLoS biology. https://doi.org/10.1371/journal.pbio.2005907

Source records